Abbvie Inc
NYSE:ABBV
Abbvie Inc
Non-Reccuring Items
Abbvie Inc
Non-Reccuring Items Peer Comparison
Competitive Non-Reccuring Items Analysis
Latest Figures & CAGR of Competitors
Company | Non-Reccuring Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Abbvie Inc
NYSE:ABBV
|
Non-Reccuring Items
-$3.8B
|
CAGR 3-Years
-31%
|
CAGR 5-Years
7%
|
CAGR 10-Years
-26%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Non-Reccuring Items
-$1.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-59%
|
CAGR 10-Years
-65%
|
|
Amgen Inc
NASDAQ:AMGN
|
Non-Reccuring Items
-$189m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
8%
|
CAGR 10-Years
1%
|
|
Moderna Inc
NASDAQ:MRNA
|
Non-Reccuring Items
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Non-Reccuring Items
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Non-Reccuring Items
-$186.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Abbvie Inc's Non-Reccuring Items?
Non-Reccuring Items
-3.8B
USD
Based on the financial report for Dec 31, 2023, Abbvie Inc's Non-Reccuring Items amounts to -3.8B USD.
What is Abbvie Inc's Non-Reccuring Items growth rate?
Non-Reccuring Items CAGR 10Y
-26%
Over the last year, the Non-Reccuring Items growth was -89%. The average annual Non-Reccuring Items growth rates for Abbvie Inc have been -31% over the past three years , 7% over the past five years , and -26% over the past ten years .